The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Expert review

Medication non-adherence as a critical factor in the management of presumed resistant hypertension: a narrative review

EuroIntervention 2014;9:1102-1109. DOI: 10.4244/EIJV9I9A185

1. Institute of Nursing Science, University of Basel, Basel, Switzerland; 2. Center of Health Services and Nursing Research, KU Leuven, Leuven, Belgium; 3. School of Nursing, University of Missouri, Columbia, MO, USA; 4. Johns Hopkins

Aims: Medication non-adherence is a crucial behavioural risk factor in hypertension management. Forty-three to 65.5% of patients with presumed resistant hypertension are non-adherent.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Intracoronary versus intravenous bolus abciximab administration in patients undergoing primary percutaneous coronary intervention with acute ST-elevation myocardial infarction: a pooled analysis of individual patient data from five randomised controlled trials